GlassScriptPhysician profile
Shiji Aby
NPI 1568079366
$7,991.46
in general payments reported to CMS, 2019-2025
44 companies · $690 in 2025
The $690 reported for 2025 was more than what 78% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,204 · 2022: $2,022 · 2023: $2,978 · 2024: $1,097 · 2025: $690.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,532 · Education: $233.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,531.75 |
| Education | $233.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,307.86 | 2021-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Astrazeneca Pharmaceuticals LP | $1,016.75 | 2021-2025 | Fasenra, Breztri, Airsupra |
| Takeda Pharmaceuticals U.S.A., INC. | $672.80 | 2021-2024 | Glassia |
| Boehringer Ingelheim Pharmaceuticals, INC. | $563.20 | 2021-2025 | Ofev, Stiolto Respimat, Jardiance |
| Actelion Pharmaceuticals US, INC. | $477.12 | 2021-2025 | Opsumit, Uptravi |
| Regeneron Healthcare Solutions, INC. | $476.73 | 2021-2024 | Dupixent |
| Mallinckrodt Hospital Products INC. | $436.13 | 2021-2025 | Acthar |
| Genzyme Corporation | $399.10 | 2021-2025 | |
| Grifols USA, LLC | $325.41 | 2021-2025 | Prolastin-C Liquid |
| Electromed, INC. | $264.79 | 2021-2024 | Smartvest |
| Pulmonx Corporation | $263.16 | 2023-2025 | Zephyr Endobronchial Valve, Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console |
| Ani Pharmaceuticals, INC. | $161.29 | 2023-2024 | Purified Cortrophin Gel |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $153.05 | 2023-2025 | Lifevest |
| Vanda Pharmaceuticals INC. | $136.80 | 2021-2022 | |
| Medtronic, INC. | $126.67 | 2024 | Linq II |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $109.35 | 2021-2025 | |
| Insmed, INC. | $95.33 | 2025 | Arikayce, Brinsupri |
| Covis Pharma Gmbh | $95.11 | 2022 | |
| Inogen, INC. | $94.87 | 2023-2024 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Viatris Specialty LLC | $79.27 | 2025 | Yupelri |
| Lexicon Pharmaceuticals, INC. | $63.85 | 2024 | |
| Sanofi-Aventis U.S. LLC | $59.99 | 2023 | |
| Amgen INC. | $58.66 | 2024 | Repatha |
| Merck Sharp & Dohme LLC | $52.30 | 2024 | Verquvo |
| United Therapeutics Corporation | $50.81 | 2023-2024 | Tyvaso |
| Pfizer INC. | $43.14 | 2024 | |
| Philips North America LLC | $41.44 | 2023-2024 | (Ak6) Vest Therapy |
| Genentech USA, INC. | $41.18 | 2021-2022 | |
| Verona Pharma, INC. | $39.29 | 2025 | Ohtuvayre |
| Resmed Corp | $30.64 | 2022 | |
| Inari Medical, INC. | $27.78 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Baxter Healthcare | $22.86 | 2023 | Hillrom - Life 2000 Ventilation System |
| Vapotherm INC | $21.87 | 2022 | |
| Kiniksa Pharmaceuticals International, Plc | $21.31 | 2024 | Arcalyst |
| Biogen, INC. | $18.10 | 2021 | |
| Janssen Pharmaceuticals, INC | $17.92 | 2024 | Xarelto |
| Mylan Specialty L.P. | $17.45 | 2021 | |
| Axsome Therapeutics, INC. | $16.68 | 2023 | Sunosi |
| Bayer Healthcare Pharmaceuticals INC. | $16.43 | 2021 | |
| Chiesi USA, INC. | $16.39 | 2024 | Kengreal |
| Phadia US INC. | $16.08 | 2024 | Immunocap |
| Alexion Pharmaceuticals, INC. | $14.49 | 2021 | |
| Novartis Pharmaceuticals Corporation | $14.12 | 2023 | |
| Pharming Healthcare, INC. | $13.89 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shiji Aby listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.